Combined use of adenosine and amrinone inhibits reperfusion injury of rat liver

Pathophysiology

Volumn 8, Issue 1, 2001, Pages 29-34

  Katsuragi, Kunihiro ^a   Takemura, Shigekazu ^a   Minamiyama, Yukiko ^a   Tanaka, Hiromu ^a   Hirohashi, Kazuhiro ^a   Inoue, Masayasu ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine; Amrinone; Ischemia reperfusion injury; Liver; Phosphodiesterase inhibitor

Indexed keywords

ADENOSINE; ALANINE AMINOTRANSFERASE; AMRINONE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; NITRATE; NITRITE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEMODYNAMICS; HYPOTENSION; LIVER CIRCULATION; LIVER ISCHEMIA; LIVER LEVEL; MALE; MICROCIRCULATION; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034901252     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(01)00062-1     Document Type: Article

References (32)

1. Post-ischemic intraportal adenosine administration protects against reperfusion injury of canine liver
2. Adenosine regulation of mesenteric vasodilation
3. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans
4. Characterization of adenosine-induced respiratory depression in the preterm rabbit
5. Characterization and expression of the human A2a adenosine receptor gene
6. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation
7. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor
8. Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules
9. Leukocyte adherence in rat mesenteric venules: Effects of adenosine and methotrexate
10. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins
11. Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: Effects of adenosine
12. Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils
13. Adenosine: A physiological modulator of superoxide anion generation by human neutrophils
14. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils
15. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively
16. Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase
17. Cardiovascular purinoceptors
18. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: Hepatic arterial buffer response
19. Two distinct adenosine-sensitive sites on adenylate cyclase
20. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells
21. Adenosine enhances nitric oxide production by vascular endothelial cells
22. Multiple cyclic nucleotide phosphodiesterases
23. The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle
24. In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides
25. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine
26. Endothelium-dependent relaxation of rat thoracic aorta by amrinone-induced nitric oxide release
27. Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells
28. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats
29. Neutrophil adhesion to histamine stimulated cultured endothelial cells is primarily mediated via activation of phospholipase C and nitric oxide synthase isozymes
30. The beneficial effect of dibutyryl cyclic adenosine monophosphate on warm ischemic injury of the rat liver induced by cardiac arrest
31. Role of nitric oxide synthase III and guanosine 3′,5′-cyclic monophosphate in the protection exerted by nitric oxide on hepatic ischemia-reperfusion injury
32. Limitations of exogenous L-arginine in exerting a cytoprotective effect on hepatic ischemia/reperfusion injury